Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety alerts Naloxone – Patient Safety Alert NHS England has produced a Patient Safety Alert warning of the risk of distress and death from inappropriate doses of naloxone in patients on long-term opioid treatment (NHS/PSA/W/2014/016R). The alert […]
Latest articles
SHORTCUTS
Eur J Pain. 2014 Aug 4. doi: 10.1002/ejp.567. [Epub ahead of print] A systematic review of therapeutic interventions to reduce acute and chronic post-surgical pain after amputation, thoracotomy or mastectomy Humble SR, Dalton AJ, Li L In this systematic review of perioperative interventions reducing acute and chronic pain associated with amputation, mastectomy or thoracotomy, 32 […]
Letter to the Editor – The use of the Deprivation of Liberty Safeguards in Palliative Care and the Cheshire West judgment: A Missed Opportunity?
To the Editor, The Deprivation of Liberty Safeguards (DoLS) were introduced on the 1st April 2009 to provide a framework for the lawful detention of individuals in hospitals (including hospices) or care homes who are unable to consent to their placement.1 The DoLS have come under increased scrutiny this year due to the Supreme Court […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Drug updates Nitrofurantoin contra-indications updated The guidance for using nitrofurantoin in renal impairment has changed. Nitrofurantoin is now contra-indicated in patients with an estimated glomerular filtration rate (eGFR) of <45mL/min/1.73m2. However, a short course (3–7 days) may be […]
Palliating Social Media – a seminar workshop at the Macmillan Professionals Conference in London
Dr Clifford Jones a Macmillan GP Facilitator in Aneurin Bevan Healthboard summarises a workshop seminar he attended at a Macmillan GP conference in London. Conference Twitter hashtag: #Macmillanpros What happens to our presence on social media when we die? And how do palliative care patients and professionals use social media? These were some of […]
SHORTCUTS
Cancer Med. 2014 Aug 26. doi: 10.1002/cam4.316. [Epub ahead of print] Incidence and risk factors for suicide and attempted suicide following a diagnosis of hematological malignancy Hultcrantz M, Svensson T, Derolf AR, Kristinsson SY, Lindqvist EK, Ekbom A, Granath F, Björkholm M In this Swedish population-based study of nearly 50,000 patients with haematological malignancies and […]
News and updates from www.palliativedrugs.com
Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website. Safety alerts Dexamethasone 4mg/mL injection changes Dexamethasone injection 4mg/mL (Organon) has been acquired by Aspen pharmaceuticals. They have reformulated the product and it now contains 3.8mg/mL dexamethasone, available as a 1mL vial, which requires storage in a […]
Psychology and palliative care services working together- on cultivating multi-disciplinary meetings and ensuring compassion in care
by Dr Katherine Regan, Clinical Psychologist, Wales, UK Dr Regan shares her experiences working in close collaboration with a specialist palliative care team at Velindre Cancer Centre in Cardiff, Wales. She discusses why collaborative working across both areas is a useful model for the future and how both fields can learn much from one another. […]
SHORTCUTS
J Pain Symptom Manage. 2014 Aug 14. pii: S0885-3924(14)00404-7. doi: 10.1016/j.jpainsymman.2014.07.007. [Epub ahead of print] Avoidable and Unavoidable Visits to the Emergency Department Among Patients With Advanced Cancer Receiving Outpatient Palliative Care Delgado-Guay MO, Kim YJ, Shin SH, Chisholm G, Williams J, Allo J, Bruera E Using information from 200 randomly selected advanced cancer patients […]
SHORTCUTS
Cochrane Database Syst Rev. 2014 Jul 24;7:CD010958. doi: 10.1002/14651858.CD010958.pub2. Topical lidocaine for neuropathic pain in adults Derry S, Wiffen PJ, Moore RA, Quinlan J. In a systematic review of randomised, double-blind studies of at least two weeks’ duration, the analgesic efficacy and adverse effects of topical lidocaine for chronic neuropathic pain was evaluated. 12 studies […]